Teva Pharmaceutical Industries (NYSE: TEVA) shares as of market close today will be eligible for a dividend of 27 cents per share. At a price of $39.90 as of 9:36 a.m. ET, the dividend yield is 2.4%. The average volume for Teva Pharmaceutical Industries has been 4.1 million shares per day over the past 30 days. Teva Pharmaceutical Industries has a market cap of $33.4 billion and is part of the drugs industry. Shares are up 6.6% year to date as of the close of trading on Tuesday. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys dividend stocks that have the potential for a 3% to 4% yield and 10% growth. Get his best picks for less than $50/year. Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. The company has a P/E ratio of 17.44. TheStreet Ratings rates Teva Pharmaceutical Industries as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. You can view the full Teva Pharmaceutical Industries Ratings Report now.
- See our top-yielding stocks list.
- See our dividend calendar.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts